MMS Earnings Date: Nov 19, 2026 (Estimated) — Maximus, Inc.
NYSE · Industrials · Specialty Business Services
Updated
When is MMS's next earnings date?
Maximus, Inc. (MMS) is expected to report Q4 2026 earnings on Thursday, November 19, 2026 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.85 on revenue of $1.30B.
How did MMS do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q3 2026), Maximus, Inc. posted EPS of $2.22 versus the $2.21 estimate, a beat of 0.9%. Revenue was $1.28B against a $1.33B estimate. The stock's 1-day post-earnings move was -7.6%.
How much does MMS stock move after earnings?
MMS beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.2% (up or down) in the day after earnings.
About Maximus, Inc.
Maximus, Inc. specializes in delivering business process services (BPS) tailored for governmental health and human welfare initiatives. Its operations are structured into three main divisions: U.S. Services, U.S. Federal Services, and International Services. The U.S. Services division delivers a wide array of BPS solutions to state and local government programs across the United States. These offerings encompass program administration, handling appeals and evaluations, and providing specialized consulting. Key programs supported include the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, and child support initiatives, alongside Preadmission Screening and Resident Reviews and Independent Developmental Disability assessments. Furthermore, this segment facilitates program eligibility and enrollment, operates centralized multilingual contact centers with multichannel and digital self-service capabilities, offers application assistance and impartial health plan selection guidance, and conducts outreach, education, eligibility determination, enrollment, and redetermination for beneficiaries. It also performs person-centered independent assessments for disability, long-term illness, and other health conditions, complemented by targeted consulting services. The U.S. Federal Services segment focuses on providing critical support to federal government agencies. Its services include establishing and managing centralized citizen engagement centers, overseeing document and record management, offering case management and direct citizen support, and delivering consumer education. This division also handles independent medical reviews, appeals for worker's compensation benefits, Medicare and Medicaid appeals, and eligibility appeals for the federal marketplace. Additionally, it contributes to the modernization of systems and IT infrastructure, provides operational support for infrastructure, offers software development, operations, and management, and specializes in data analytics. Internationally, the company's "Outside the U.S." segment delivers BPS offerings to both governmental bodies and commercial enterprises. These services include health and disability evaluations, the administration of employment programs, and various other services aimed at assisting job seekers. Established in 1975, Maximus, Inc. maintains its corporate headquarters in Tysons, Virginia.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q3 2026 | 2.21 | 2.22 | +0.91% | $1.28B | ✅ Beat | -7.63% | -13.79% | -6.93% |
| 2026-05-07 | Q2 2026 | 1.98 | 2.07 | +4.55% | $1.31B | ✅ Beat | +4.24% | -7.05% | -4.81% |
| 2026-02-05 | Q1 2026 | 1.83 | 1.85 | +1.09% | $1.34B | ✅ Beat | -16.51% | -19.12% | -16.36% |
| 2025-11-20 | Q4 2025 | 1.65 | 1.62 | -1.82% | $1.32B | ❌ Miss | +5.53% | +10.88% | +13.29% |
| 2025-02-06 | Q1 2025 | 1.06 | 1.61 | +51.89% | $1.40B | ✅ Beat | -7.69% | -11.42% | -5.72% |
| 2024-11-20 | Q4 2024 | 1.48 | 1.46 | -1.35% | $1.32B | ❌ Miss | -6.92% | -9.97% | -9.42% |
| 2024-08-07 | Q3 2024 | 1.34 | 1.74 | +29.85% | $1.31B | ✅ Beat | -0.23% | +0.43% | -0.17% |
| 2024-05-08 | Q2 2024 | 1.02 | 1.57 | +53.92% | $1.35B | ✅ Beat | -0.53% | +3.82% | +1.50% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $620.3M total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Clinical Services | 89.2% | $553.1M | -1.3% | $471.5M | $504.0M | $560.4M | $565.1M |
| Technology Solutions | 10.8% | $67.2M | -15.1% | $89.6M | $88.1M | $79.2M | — |
By region
Q4 FY22 · $1.18B total
| Segment | Share | Revenue | YoY | Q2 FY21 | Q3 FY21 | Q4 FY21 | Q1 FY22 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 85.2% | $1.00B | +7.5% | $778.4M | $1.05B | $932.9M | $968.3M |
| UNITED KINGDOM | 9.1% | $107.1M | +43.5% | $72.9M | $74.1M | $74.7M | $85.8M |
| Rest of World | 3.1% | $37.1M | -18.9% | $37.1M | $50.2M | $45.7M | $44.0M |
| AUSTRALIA | 2.5% | $30.0M | -43.2% | $70.9M | $65.3M | $52.8M | $52.8M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.